More
    Guided Solutions - Connecting Talent With Innovation/div>

    SK Capital Makes Strategic Investment in Spectrum Vascular

    Spectrum Vascular, a provider of vascular access and medication management products designed to reduce health care-acquired infections, announced today a strategic investment by an...

    Supira Medical nets $120m to advance ventricular support device

    US-based Supira Medical has completed a $120m Series E funding round, with plans to use the capital to advance its position in the percutaneous...

    Evident Vascular closes Series B for AI-powered intravascular ultrasound

    Evident Vascular announced today that it closed a Series B financing round to support its AI-powered intravascular ultrasound (IVUS) platform. The San Jose, California-based company...

    Proscia scoops $50m for AI-driven pathology advancement

    A US-based pathology software provider has completed a $50m fund raise to advance its artificial intelligence (AI)-driven digital pathology platform. Currently used by 16 of...

    Sibel Health raises $30 million, adds seventh FDA clearance

    Sibel Health closed a $30 million equity financing and earned its seventh FDA 510(k) clearance. Existing investors, the Steele Foundation for Hope and Dräger,...

    Cardiac Dimensions snags $53m for mitral valve device

    Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s mitral valve repair device. The...

    Brainomix concludes $18m fund raise to strengthen US presence

    UK-based Brainomix has completed a £14m ($18m) Series C funding round to advance commercial expansion in the US. A spinout of Oxford University, the company’s...

    Eventum Orthopaedics secures £3.8m following knee op device roll-out

    Eventum Orthopaedics, manufacturers of a device that it says could ‘revolutionise’ knee replacement surgery has raised a further 3.8 million GBP from NPIF II...

    Laplace Interventional raises $22m for tricuspid valve tech

    Laplace Interventional announced it completed a Series C financing round to support its prosthetic heart valve technology. An undisclosed global strategic investor led the financing...

    Latest articles